$4.34
3.56%
Nasdaq, Oct 05, 04:00 pm EDT. Closed.
ISIN
KYG9442G1047
Symbol
UPC

Universe Pharmaceuticals INC Stock price

$4.34
+0.31 7.69% 1M
+1.41 48.12% 6M
+0.53 13.91% YTD
-0.40 8.44% 1Y
-691.66 99.38% 3Y
-8,779.66 99.95% 5Y
-17,095.66 99.97% 10Y
-17,095.66 99.97% 20Y
Nasdaq, Closing price Mon, Oct 05 2026
-0.16 3.56%
ISIN
KYG9442G1047
Symbol
UPC
Industry

Is Universe Pharmaceuticals INC a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.

Key metrics

Basic
Market capitalization
$21.8m
Enterprise Value
$-2.5m
Net debt
positive
Cash
$33.6m
Shares outstanding
560.0k
Valuation
P/E
negative
P/S | estimate
1.2 | -
EV/Sales | estimate
negative | -
EV/FCF | ex SBC
0.5 | -
P/B
0.4
Financial Health
Equity Ratio
81.0%
Return on Equity
-6.5%
ROCE
-5.2%
ROIC
-9.1%
Debt/Equity
0.2
Financials
Revenue | estimate
$17.9m | -
EBITDA
$-2.4m
EBIT
$-2.9m
Net Income
$-3.7m
Free Cash Flow | ex SBC
$-5.4m | -
Growth
Revenue | estimate
-22.4% | -
EBITDA
69.1%
EBIT
63.6%
Net Income
58.0%
Free Cash Flow
45.1%
Margin
Gross
35.3%
EBITDA
-13.4%
EBIT
-16.3%
Net
-20.6%
Free Cash Flow | ex SBC
-30.2% | -
More
EPS
$-6.5
FCF per Share
$-9.6
Short interest
1.5%
Employees
225
Rev per Employee
$80.0k

Financial data from Universe Pharmaceuticals INC

Sep '25
+/-
%
18 18
22% 22%
100%
- Direct Costs 12 12
32% 32%
65%
6.30 6.30
4% 4%
35%
- Selling and Administrative Expenses 8.55 8.55
21% 21%
48%
- Research and Development Expense 0.67 0.67
78% 78%
4%
-2.40 -2.40
69% 69%
-13%
- Depreciation and Amortization 0.52 0.52
108% 108%
3%
EBIT (Operating Income) EBIT -2.92 -2.92
64% 64%
-16%
Net Profit -3.67 -3.67
58% 58%
-21%

In millions USD.

Don't miss a Thing! We will send you all news about Universe Pharmaceuticals INC directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Universe Pharmaceuticals INC Stock News

Neutral
GlobeNewsWire
●
3 months ago
Ji'an, Jiangxi, China, June 26, 2026 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company has entered into a share purchase agreement to acquire 100% of the issued shares of Best Praise International Limited (“Best Praise”), a company that holds five pate...
Neutral
Business Wire
●
4 months ago
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. today announced a significant and far-reaching victory in the Unified Patent Court (UPC) in Germany, which ruled that Siemens* infringed upon a critical Hologic mammography technology patent in Siemens' latest mammography system. The court imposed a sweeping injunction, immediately prohibiting Siemens from making, offering, placing on the marke...

Company Profile

Universe Pharmaceuticals, Inc. manufactures, markets, and distributes traditional derivative products. It also sells biomedical drugs, medical instruments, traditional and dietary supplements manufactured by third-party pharmaceutical companies. The company was founded on December 12, 1998 and is headquartered in Ji'an, China.

Head office Cayman Islands
CEO Mr. Lai
Employees 225
Founded 1998
Website www.universe-pharmacy.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today